Julie Ann Carlson MD (She/Her)
Breast Cancer, Central Nervous System Cancer, Thoracic Cancer
Physician
Join to View Full Profile
400 Indiana StreetSuite 220Golden, CO 80401
Phone+1 303-467-8903
Fax+1 303-467-8921
Dr. Carlson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Julie Carlson is a radiation oncologist in Golden, CO and is affiliated with SCL Health - Lutheran Medical Center. She received her medical degree from University of Colorado School of Medicine and has been in practice 7 years. She specializes in breast cancer, central nervous system cancer, and thoracic cancer. She has 5 publications and over 100 citings.
Education & Training
University of Colorado School of Medicine Anschutz Medical CampusClass of 2010
Harvard AB, Biology, 1999 - 2003
Certifications & Licensure
CO State Medical License 2015 - 2027
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Gold Humanism Honor Society Arnold P. Gold Foundation, 2012
- Radiation Oncology Chief Resident University of Colorado Department of Radiation Oncology, 2009-2010
- Alpha Omega Alpha Alpha Omega Alpha Honor Medical Society, 2009
Publications & Presentations
PubMed
- 43 citationsCombination of Trastuzumab Emtansine and Stereotactic Radiosurgery Results in High Rates of Clinically Significant Radionecrosis and Dysregulation of Aquaporin-4Priscilla K. Stumpf, Diana M. Cittelly, Tyler P. Robin, Julie A. Carlson, Kelly Stuhr
Clinical Cancer Research. 2019-07-01 - 9 citationsExternal Validation of the Benefit of Adjuvant Radiotherapy for Pathologic N1M0 Prostate CancerChad G. Rusthoven, Julie A. Carlson, Brian D. Kavanagh
Journal of Clinical Oncology. 2015-06-10 - 23 citationsHypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM...Julie A. Carlson, Krishna Reddy, Laurie E. Gaspar, Douglas E. Ney, Brian D. Kavanagh
Journal of Neuro-Oncology. 2015-04-29
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
